How Kratom Works: A Clear, Evidence Based Look at Mitragynine, the Body, and Opioid Receptors

Kratom (Mitragyna speciosa) has gained attention in recent years for its unique pharmacology and its potential role as a safer alternative to traditional opioids. Unlike sensationalized media narratives, the science paints a more nuanced picture: kratom’s primary alkaloids interact with the body in ways that are measurably different from classical opioids, especially regarding respiratory depression and addiction risk.

This article breaks down how kratom works, how mitragynine is metabolized, its interaction with the mu‑opioid receptor, and why its risk profile differs from conventional opioids, using data from the American Kratom Association (AKA) and peer‑reviewed research.

What Are Kratom’s Primary Active Alkaloids?

Kratom contains over 40 alkaloids, but two are most pharmacologically relevant:

• Mitragynine (MG) – the dominant alkaloid, making up ~60% of total alkaloid content.
• 7‑Hydroxymitragynine (7‑OH) – a trace alkaloid occurring naturally in extremely small amounts.

According to the AKA, 7‑OH exists naturally only in minute, biologically insignificant quantities, and concerns arise primarily from synthetic or adulterated products, not natural kratom leaf.

How Kratom Works in the Body

1. Mitragynine’s Interaction With the Mu‑Opioid Receptor

Scientific studies show that mitragynine acts as a partial agonist at the mu‑opioid receptor (MOR) — the same receptor targeted by opioids like oxycodone or morphine.

A major study published in Scientific Reports (Nature) mapped this interaction and found:

• Mitragynine binds to the mu‑opioid receptor.
• It activates the receptor only partially, unlike full agonists such as morphine.
• This partial activation produces analgesia and mood effects without triggering the same level of respiratory depression seen in classical opioids.

This partial agonism is one of the key reasons kratom behaves differently from traditional opioids.

2. Mitragynine’s Conversion Into 7‑Hydroxymitragynine

The body metabolizes mitragynine primarily in the liver. A small portion is converted into 7‑hydroxymitragynine, which has a stronger affinity for the mu‑opioid receptor.

Key findings from pharmacological research:

• Mitragynine is metabolized via hepatic enzymes into several metabolites, including 7‑OH.
• 7‑OH is more potent at the mu‑opioid receptor, but the body produces only small amounts from natural kratom consumption.
• The conversion is slow and limited, contributing to kratom’s milder opioid‑like effects compared to pharmaceutical opioids.

A study in The Journal of Pharmacology and Experimental Therapeutics demonstrated that both mitragynine and 7‑OH interact with mu‑opioid receptors, but with different potency and receptor signaling profiles.

Why Kratom’s Effects Differ From Traditional Opioids

1. Partial Agonism = Lower Respiratory Depression Risk

Respiratory depression is the primary cause of fatal opioid overdoses.

Because mitragynine is a partial agonist, it does not fully activate the mu‑opioid receptor. Research suggests this results in:

• Reduced respiratory depression
• Lower overdose risk
• A “ceiling effect” on opioid‑like activity

This is a major distinction from full agonists like fentanyl or heroin.

2. Additional Non‑Opioid Mechanisms

Kratom’s pharmacology is not limited to opioid receptors. Studies show mitragynine also interacts with:

• Adrenergic α‑2 receptors (similar to clonidine)
• Serotonin receptors
• Other neuromodulatory pathways

These interactions contribute to kratom’s:

• Stimulating effects at lower doses
• Relaxing or analgesic effects at higher doses

The adrenergic α‑2 activity was specifically highlighted in the same pharmacological investigation of mitragynine and 7‑OH.

3. Lower Abuse Potential Compared to Classical Opioids

A review in Translational Psychiatry (Nature) examined kratom’s molecular mechanisms and dependence potential. It concluded:

• Kratom can produce dependence, but typically milder than classical opioids.
• Withdrawal symptoms, when present, are generally less severe.
• Kratom’s complex receptor activity may reduce compulsive use patterns seen with full opioid agonists.

The AKA also emphasizes that kratom’s traditional use in Southeast Asia spans centuries with low incidence of severe addiction, especially compared to Western opioid misuse.

What Effects Do Users Commonly Report?

While effects vary by individual physiology and dosage, common user‑reported outcomes include:

• Increased energy and focus (lower doses)
• Improved mood and sociability
• Relief from physical discomfort
• Relaxation and calm (moderate doses)

These effects align with the dual opioid‑adrenergic activity documented in scientific literature.

Safety Considerations

A science‑based perspective acknowledges both benefits and risks:

Potential Benefits

• Lower respiratory depression risk compared to opioids
• Reduced harm profile
• Possible role in pain management
• Potential alternative for individuals seeking to avoid traditional opioids

Potential Risks

• Dependence with frequent high‑dose use
• Withdrawal symptoms
• Interaction with other substances
• Risk of adulterated or contaminated products

The AKA strongly advocates for consumer protections, including:

• GMP‑certified manufacturing
• Lab‑tested products
• Transparent alkaloid profiles
• No adulterants or synthetic 7‑OH

Conclusion: Kratom’s Unique Pharmacology Makes It Fundamentally Different From Opioids

Kratom is not a “natural opioid,” nor is it a harmless herbal supplement. The truth lies in the middle — and the science supports a balanced view:

• Mitragynine is a partial mu‑opioid agonist.
• It is metabolized into small amounts of 7‑OH.
• Its receptor activity produces analgesia and mood effects.
• Its partial agonism and multi‑pathway pharmacology contribute to a lower risk profile than traditional opioids.
• Responsible use and high‑quality products are essential.

As research continues, kratom’s potential role in harm reduction and wellness becomes increasingly clear — provided it is used responsibly and sourced from reputable vendors.